| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |